top of page

Multiple sclerosis (MS)

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, specifically the brain and spinal cord. In MS, the immune system mistakenly attacks the protective covering of nerve fibers (myelin), leading to communication disruptions between the brain and the rest of the body. This can result in a wide range of symptoms and challenges for individuals living with the condition.

    Key Points about Multiple Sclerosis:

    1. Diverse Symptoms: MS symptoms vary widely and can include fatigue, difficulty walking, numbness or tingling, muscle weakness, vision problems, and issues with coordination and balance.

    2. Relapsing-Remitting MS (RRMS): The most common form of MS is relapsing-remitting, characterized by periods of symptom flare-ups (relapses) followed by periods of recovery (remission).

    3. Progressive Forms: Some individuals may experience a gradual worsening of symptoms over time, leading to secondary progressive MS or primary progressive MS.

    4. Unknown Cause: The exact cause of MS remains unknown, but a combination of genetic and environmental factors is believed to contribute to its development.

    5. No Cure, Manageable: While there is currently no cure for MS, various treatments and therapies are available to manage symptoms, slow disease progression, and improve quality of life.

    6. Impact on Daily Life: MS can have a significant impact on daily activities, employment, and overall well-being. Adaptations, support, and medical interventions are often required to address individual needs.

    Clinical Trials and MS:

    Clinical trials play a crucial role in advancing our understanding of MS and developing new treatments. They provide opportunities for individuals with MS to access cutting-edge therapies, contribute to medical research, and potentially improve their own health outcomes.

    If you or someone you know is interested in participating in a clinical trial for multiple sclerosis, contact us at:



    -Age limit 18-50 years old

    -Must be diagnosed with Relapsing Multiple Sclerosis within 10 years

    -Participants must currently be on no more than one immunomodulatory medication

    bottom of page